Spectral AI, Inc.

Spectral AI, Inc. (Nasdaq: MDAI) is a medical artificial intelligence company focused on AI-powered wound assessment technology, having completed its de-SPAC business combination and begun trading as a public company in 2023. The company's DeepView platform uses deep learning to analyze wound tissue and predict healing outcomes, targeting burn care and chronic wound management within the broader healthcare technology sector. Spectral AI filed an 8-K current report with the Securities and Exchange Commission on August 12, 2026, under accession number 0001213900-26-088341. For the full filing history, post-merger performance data, and real-time corporate event tracking on MDAI and hundreds of other de-SPAC companies, create a free account at SpacDesk.